Patient Access Schemes in England

Executive Summary

  • A Patient Access Scheme (PAS) is an agreement between a pharmaceutical company and national funding bodies (e.g. NHS England) under which a medicine will be provided at a discount in order to improve cost-effectiveness during Health Technology Assessment (HTA)
  • A PAS can either be ‘Simple’ (an agreed discount on the list price) or ‘Complex’ (any other type of agreement), with the former being strongly preferred
  • Simple PAS discounts can be treated as commercially confidential